Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

BioInvent International

23.00 SEK

-0.43 %

Less than 1K followers

BINV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioInvent International

2019202020212022202320242025
Revenue93.7147.419.4326.171.544.7226.5
growth-%57.2 %-86.8 %1,582.5 %-78.1 %-37.5 %406.8 %
EBITDA-126.2-63.5-263.7-36.2-353.2-451.8-331.8
EBIT-137.8-75.5-278.4-50.9-369.9-471.1-351.7
Profit before taxes-138.6-76.3-278.4-42.5-330.1-429.2-332.5
Net income-138.6-76.3-278.4-42.5-330.3-429.4-332.9
EPS-6.78-1.94-5.14-0.69-5.02-6.53-5.06
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-134.7 %-43.1 %-1,360.6 %-11.1 %-494.2 %-1,010.9 %-146.5 %
EBIT-%-147.1 %-51.2 %-1,436.0 %-15.6 %-517.7 %-1,054.1 %-155.3 %
ROE-81.8 %-10.3 %-20.4 %-2.6 %-25.2 %-48.5 %-59.7 %
ROI-61.3 %-9.5 %-19.2 %-2.5 %-23.6 %-43.4 %-49.6 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.